Interestingly, CDKN2A gene mutations are found in up to 40% of familial cases of melanoma, up to 25% of head and neck squamous cell carcinomas (HNSCC), some breast cancers and pancreatic cancers, and others. This evidence concerns the gene CDKN2A and melanoma.